Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 19, 2005
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation
R Hilker, A T Portman, J Voges, et al.
BMC Neurology
|
November 21, 2015
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study
Constant V M Verschuur, S R Suwijn, B Post, et al.
Oncogene
|
September 18, 2007
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha
E H Gort, G van Haaften, I Verlaan, et al.
BMC Neurology
|
July 19, 2019
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
B R Bloem, W J Marks, A L Silva de Lima, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 19, 2005
Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation
R Hilker, A T Portman, J Voges, et al.
BMC Neurology
|
November 21, 2015
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study
Constant V M Verschuur, S R Suwijn, B Post, et al.
Oncogene
|
September 18, 2007
The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha
E H Gort, G van Haaften, I Verlaan, et al.
BMC Neurology
|
July 19, 2019
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
B R Bloem, W J Marks, A L Silva de Lima, et al.
Page
of 7